RMD

ResMed
D

RMD

239.905
USD
3.44
(1.45%)
Market Closed
Volume
24,372
EPS
9
Div Yield
0.88
P/E
27
Market Cap
35,176,646,157
Related Instruments
ALC
ALC
2.220
(2.31%)
98.300 USD
ALGN
ALGN
3.290
(1.86%)
179.880 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
MDT
MDT
1.280
(1.53%)
84.850 USD
PHG
PHG
0.615
(2.46%)
25.595 USD
PHM
PHM
2.570
(2.52%)
104.480 USD
SYK
SYK
4.11
(1.10%)
378.26 USD
More
News

Title: ResMed

Sector: Healthcare
Industry: Medical Instruments & Supplies
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.